Burgess Sarah, Jaruga Pawel, Dodson M L, Dizdaroglu Miral, Lloyd R Stephen
Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas 77555-1071, USA.
J Biol Chem. 2002 Jan 25;277(4):2938-44. doi: 10.1074/jbc.M110499200. Epub 2001 Nov 15.
Endonuclease VIII from Escherichia coli is a DNA glycosylase/lyase that removes oxidatively damaged bases. EndoVIII is a functional homologue of endonuclease III, but a sequence homologue of formamidopyrimidine-DNA glycosylase (Fpg). Using multiple sequence alignments, we have identified six target residues in endoVIII that may be involved in the enzyme's glycosylase and/or lyase functions: the N-terminal proline, and five acidic residues that are completely conserved in the endoVIII-Fpg proteins. To investigate the contribution of these residues, site-directed mutagenesis was used to create seven mutants: P2T, E3D, E3Q, E6Q, D129N, D160N, and E174Q. Each mutant was assayed both for lyase activity on abasic (AP) sites and for glycosylase/lyase activity on 5-hydroxyuracil, thymine glycol, and gamma-irradiated DNA with multiple lesions. The P2T mutant did not have lyase or glycosylase/lyase activity but could efficiently form Schiff base intermediates on AP sites. E6Q, D129N, and D160N behaved essentially as endoVIII in all assays. E3D, E3Q, and E174Q retained significant AP lyase activity but had severely diminished or abolished glycosylase/lyase activities on the DNA lesions tested. These studies provide detailed predictions concerning the active site of endoVIII.
来自大肠杆菌的核酸内切酶VIII是一种DNA糖基化酶/裂解酶,可去除氧化损伤的碱基。核酸内切酶VIII是核酸内切酶III的功能同源物,但却是甲酰胺嘧啶-DNA糖基化酶(Fpg)的序列同源物。通过多序列比对,我们在核酸内切酶VIII中鉴定出六个可能参与该酶糖基化酶和/或裂解酶功能的靶残基:N端脯氨酸,以及在核酸内切酶VIII-Fpg蛋白中完全保守的五个酸性残基。为了研究这些残基的作用,我们使用定点诱变创建了七个突变体:P2T、E3D、E3Q、E6Q、D129N、D160N和E174Q。对每个突变体进行了无碱基(AP)位点裂解酶活性以及对5-羟基尿嘧啶、胸腺嘧啶乙二醇和具有多个损伤的γ射线照射DNA的糖基化酶/裂解酶活性测定。P2T突变体没有裂解酶或糖基化酶/裂解酶活性,但能在AP位点上高效形成席夫碱中间体。E6Q、D129N和D160N在所有测定中表现基本与核酸内切酶VIII相同。E3D、E3Q和E174Q保留了显著的AP裂解酶活性,但在所测试的DNA损伤上糖基化酶/裂解酶活性严重降低或丧失。这些研究提供了有关核酸内切酶VIII活性位点的详细预测。